The IMOLEVURE brand, founded in 2002 (United States), from 2466 sister brands and 17477 competing brands. IMOLEVURE is owned by JOHNSON & JOHNSON, listed on the stock exchange of New York IMOLEVURE belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(IMOLEVURE)
over 5 years*
USD 151.47